Gilmartin Kathleen A 4/A

What Happened Kathleen A. Gilmartin, a director of U S Physical Therapy, was granted 2,306 restricted shares (transaction code A) on May 19, 2026. The amended Form 4 reports the grant price as $0.00 per share (total value $0 for reporting purposes). This filing amends the Form 4 originally filed May 20, 2026, to correct an earlier erroneous per‑share price.

Key Details

• Transaction date: 2026-05-19; amended Form 4 filed 2026-05-28 to correct the price.
• Reported price (corrected): $0.00 per share. Original filing incorrectly listed $61.61 per share (see footnote).
• Shares granted: 2,306 restricted shares (total reported value $0).
• Vesting schedule (footnote): 1,153 shares vest Aug 20, 2026; 576 shares vest Nov 20, 2026; 577 shares vest Mar 6, 2027 — vesting contingent on her remaining a director on those dates.
• Shares owned after transaction: not specified in the amendment.
• Filing note: This is a corrective amendment to fix the transaction price; no other changes reported.

Context This was an equity award of restricted stock (compensation/retention), not an open-market buy or sale. Restricted stock grants are common director compensation and only become unrestricted as they vest; they do not necessarily indicate the director is buying or selling for liquidity or signaling a view on the stock. The amendment corrects reporting accuracy—important for transparency but not evidence of trading activity.